# Ensysce Biosciences Reports First Quarter 2026 Financial Results
Canonical URL: https://biopharmsignal.com/news/ENSC/ensysce-biosciences-reports-first-quarter-2026-financial-results
Ticker: ENSC
Company: Ensysce Biosciences
Source: Ensysce Biosciences
Published: 2026-05-15 20:15 EST
Original Source URL: https://ir.ensysce.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-14 12:00 EST — [Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant](https://biopharmsignal.com/news/ENSC/ensysce-biosciences-awarded-5-3-million-installment-in-nida-funding-completing-m-ee1ecc0e) — Source: Ensysce Biosciences
- 2026-06-26 12:00 EST — [Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study](https://biopharmsignal.com/news/ENSC/ensysce-biosciences-enrolls-first-patient-in-final-phase-of-pf614-mpar-102-clini-3e521199) — Source: Ensysce Biosciences
- 2026-05-15 20:15 EST — [Ensysce Biosciences Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/ENSC/ensysce-biosciences-reports-first-quarter-2026-financial-results) — Source: Ensysce Biosciences
- 2026-05-12 12:00 EST — [Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology](https://biopharmsignal.com/news/ENSC/ensysce-biosciences-announces-expansion-of-patent-protection-for-groundbreaking-mpar-r-overdose-protection-technology) — Source: Ensysce Biosciences
- 2026-05-08 12:00 EST — [Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam](https://biopharmsignal.com/news/ENSC/ensysce-biosciences-ceo-presents-at-inaugural-clinical-pain-symposium-in-amsterdam) — Source: Ensysce Biosciences
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)